(a) the details of the IPR applications by pharmaceutical companies rejected by the Indian patent office in the last three years;
(b) the number of applications rejected citing Section 3(d) of the Indian Patents Act (IPA) in the last three years; and
(c) the keypoints of the reforms in IPR suggested by the Committee under Department of Industrial Promotion and Policy?
???????? ??? ?????? ???????????? (????????? ??????)(??????? ??????? ???????)
THE MINISTER OF STATE (INDEPENDENT CHARGE)
OF THE MINISTRY OF COMMERCE & INDUSTRY
(SHRIMATI NIRMALA SITHARAMAN)
(a): A total of 955 patent applications in pharmaceutical field have been rejected by Indian Patent Office in the last three years.
(b): A total of 618 applications have been rejected citing Section 3(d) of the Patents Act 1970 as one of the grounds for rejection in the last three years.
(c): No such committee has been formed by the Department of Industrial Policy and Promotion to suggest key reforms in the IPR.
*********